Humacyte HUMA
NASDAQ HUMA
$0.66 -0.02 (-2.45%)
As of: Aug 21, 2026 · 1:07 PM EDT

Humacyte (HUMA) EPS (Basic) (2020 - 2026)

Humacyte (HUMA) posted quarterly EPS (Basic) of -$0.16 for Q1 2026, up 19.73% year-over-year from -$0.13 in Q1 2025, and up 20.26% quarter-over-quarter from -$0.2 in Q4 2025.

Humacyte (HUMA) EPS (Basic) (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has reported EPS (Basic) for 7 consecutive years, with -$0.16 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 19.73% year-over-year to -$0.16; the TTM figure through Mar 2026 stood at -$0.91 (down 1.51% YoY), while the FY2025 annual figure was -$0.74, up 70.15% from the prior year.
  • EPS (Basic) rose to -$0.16 in Q1 2026 per HUMA's latest filing, from -$0.2 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.16 in Q1 2026 and bottomed at -$0.54 in Q3 2025.
  • Historically, EPS (Basic) has averaged -$0.25 across 5 years, with a median of -$0.24 in 2023.
  • Annual changes were most pronounced in 2022 — EPS (Basic) soared 95.34% — and 2025, when it plunged 104.28%.
  • Humacyte's EPS (Basic) stood at -$0.2 in 2022, then slumped by 42.07% to -$0.29 in 2023, then advanced by 14.58% to -$0.25 in 2024, then grew by 21.04% to -$0.2 in 2025, then increased by 20.26% to -$0.16 in 2026.
  • Business Quant data shows HUMA's EPS (Basic) at -$0.16 in Q1 2026, -$0.2 in Q4 2025, and -$0.54 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.66 Bn 131.80 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.52 Bn 78.53 Bn 3.93 Bn 12.62
3 Argenx Se 65.33 Bn 60.14 Bn 1.37 Bn 7.59
4 Moderna 59.76 Bn 54.62 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.15 Bn 37.05 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.84 Bn 28.53 Bn 992.69 Mn 1.23
7 BioNTech SE 28.23 Bn 9.84 Bn 668.28 Mn -0.72
8 Insmed 27.52 Bn 26.36 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.29 Bn 26.46 Bn - 0.18
10 Humacyte 155.66 Mn 155.66 Mn -825,000.00 -0.12

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.15
Mar 31, 2026 -0.16
Dec 31, 2025 -0.20
Sep 30, 2025 -0.54
Jun 30, 2025 -0.20
Mar 31, 2025 -0.19
Dec 31, 2024 -0.25
Sep 30, 2024 -0.27
Jun 30, 2024 -0.26
Mar 31, 2024 -0.25
Dec 31, 2023 -0.29
Sep 30, 2023 -0.24
Jun 30, 2023 -0.26
Mar 31, 2023 -0.22
Dec 31, 2022 -0.20
Sep 30, 2022 -0.24
Jun 30, 2022 -0.19
Mar 31, 2022 -0.29
Dec 31, 2021 -0.58
Sep 30, 2021 -0.72